Association of Interleukin-17F Polymorphism and Mortality Predictors with the Risk of COVID-19

Table 4

Univariate and multivariate logistic regression analyses to identify predictors of mortality in the study COVID-19 patients (n = 135).

Variable	Univariate			Multivariate
	Value	COR	95% CI	Value	OR	95% CI
Age (years)
≤57	<0.001	r (1)	r (1)	0.002	r (1)	r (1)
>57		5.1	2.2–11.6		11.2	2.4–53.1
Blood pressure
Normotensive	0.008	r (1)	1.4–7.4	0.013	17.7	r (1)
Hypertensive		3.2				1.8–172.2
Associated comorbidities
≤2	0.045	r (1)	1.02–5.4	0.380	r (1)	r (1)
>2		2.4			0.38	0.04–3.3
RR (breaths/minute)
≤28	<0.001	r (1)	4.8–28	0.058	5.9	0.94–36.4
>28		11.5
Modified MRC Dyspnea Scale
≤3	<0.001	r (1)	r (1)	0.8	r (1)	r (1)
>3		6.9	3.1–15		1.2	0.28–4.9
Clinical severity
Noncritical	<0.001	r (1)	r (1)	0.057	r (1)	r (1)
Critical		25.4	5.7–111.7		21.1	0.91–487.2
Duration of hospital stay (days)
≤8	0.008	r (1)	1.3–5.6	0.381	r (1)	r (1)
>8		2.7			2.2	0.38–12.6
WBCs (× 10 ^3 per mm ^3 )
≤12.6	<0.001	r (1)	r (1)	0.022	r (1)	r (1)
>12.6		4.7	2–11		8	1.4–47.7
CRP (mg/L)
≤98	<0.001	r (1)	r (1)	0.392	r (1)	r (1)
>98		3.9	1.9–8.2		1.9	0.43–8.7
D-dimer (ng/ml)
≤0.9	<0.001	r (1)	r (1)	<0.001	r (1)	r (1)
>0.9		12.2	5.3–28.1		17.9	3.1–103
CT severity
Mild to moderate	<0.001	r (1)	r (1)	0.116	r (1)	r (1)
Severe		54.5	7.2–414.6		10.7	0.56–206.4

CRP:C-reactive protein; RR: respiratory rate; WBCs: white blood cells.